{"url_path":"/sec/nvax/8-k/2026-02-26/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-02-26","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/0001000694-26-000011-index.html","accession_number":"0001000694-26-000011","cik":"0001000694","ticker":"NVAX","issuer_name":"NOVAVAX INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1000694/0001000694-26-000011-index.html","primary_entity_key":"0001000694","primary_entity_name":"NOVAVAX INC"},"word_count":90,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No. Description\n\n[99.1](nvaxq4-25earningspressrele.htm)\n \n[Press release, dated](nvaxq4-25earningspressrele.htm)[Febr](nvaxq4-25earningspressrele.htm)[uary 26, 2026](nvaxq4-25earningspressrele.htm)[, regarding the Company’s financial results for the quarter ended](nvaxq4-25earningspressrele.htm)[December](nvaxq4-25earningspressrele.htm)[3](nvaxq4-25earningspressrele.htm)[1](nvaxq4-25earningspressrele.htm)[, 202](nvaxq4-25earningspressrele.htm)[5](nvaxq4-25earningspressrele.htm)[.](nvaxq4-25earningspressrele.htm)\n\n104 Cover Page Interactive Data File (formatted as Inline XBRL).\n\n \n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n NOVAVAX, INC.\n\n   \n\nDate: February 26, 2026\nBy:/s/ Mark J. Casey\n\n Name:Mark J. Casey\n\n Title:Executive Vice President, Chief Legal Officer and Corporate Secretary"}